Estimation of Apolipoproteins with OxLDL in Male Patients with Hypertension.
Al-Furat Journal for Health and Medical Sciences · 15.06.2026 · 2 (2) · 430-438
DOI: 10.46649/qy4ay262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Furat Journal for Health and Medical Sciences, online erschienen am 15.06.2026.
Abstract (Originalsprache)
Obesity and hypertension are critical risk factors for cardiovascular disease (CVD). Adipose tissue dysfunction in obesity promotes a pro-inflammatory, pro-atherogenic state via altered adipokine secretion (e.g., resistin), dyslipidemia, and increased oxidized low-density lipoprotein (OxLDL).To investigate the correlation between serum resistin, Apolipoprotein A1 (ApoA1), Apolipoprotein B100 (ApoB100), and oxidized low-density lipoprotein (OxLDL) with body mass index (BMI) and lipid profiles in healthy, obese, hypertensive, and obese hypertensive males.In this cross-sectional comparative study of 60 males, serum resistin, ApoA1, ApoB100, and OxLDL were quantified by ELISA. Lipid profiles were determined using standard enzymatic methods. Relationships between biomarkers, BMI, and lipid parameters were assessed using Pearson's correlation with Bonferroni correction applied for multiple comparisons.BMI was positively correlated with OxLDL (r=0.507, p
Zitieren
APA
(2026). Estimation of Apolipoproteins with OxLDL in Male Patients with Hypertension. Al-Furat Journal for Health and Medical Sciences, 2(2), 430-438. https://doi.org/10.46649/qy4ay262
Vancouver
Estimation of Apolipoproteins with OxLDL in Male Patients with Hypertension. Al-Furat Journal for Health and Medical Sciences. 2026;2(2):430-438. doi:10.46649/qy4ay262
BibTeX
@article{euvimed2026,
title = {Estimation of Apolipoproteins with OxLDL in Male Patients with Hypertension},
journal = {Al-Furat Journal for Health and Medical Sciences},
year = {2026},
volume = {2},
number = {2},
pages = {430--438},
doi = {10.46649/qy4ay262}
}
EUVIMED